Condition
Skin Necrosis
Total Trials
5
Recruiting
1
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 1 (1)
Trial Status
Not Yet Recruiting2
Completed1
Unknown1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07340632Not ApplicableNot Yet RecruitingPrimary
B4P Trial - BLOOM43 for Preconditioning
NCT06956443Not Yet Recruiting
Prediction of ICG for Skin Necrosis in Mastectomy With Immediate Reconstruction
NCT05910931RecruitingPrimary
Efficacy of Angiography With Indocyanine Green in the Identification of Complications After Breast Surgery
NCT02145130Phase 1Completed
Phase I Study for Autologous Dermal Substitutes and Dermo-epidermal Skin Substitutes for Treatment of Skin Defects
NCT01378845Not ApplicableUnknown
Prognostic Influence of Light Rheography Measurement of Patients With Secondary Raynaud Syndrome With Ulcers on Hands
Showing all 5 trials